13F HOLDINGS REPORT
Saturn V Capital Management LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001964437-25-000003
Total Value
$255.4M
Positions
24
Other Managers
0
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DISC MEDICINE INC | IRON | 509,406 | $32.3M | 12.65% |
| 2 | ASCENDIS PHARMA A/S | ASND | 198,977 | $27.4M | 10.73% |
| 3 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 346,111 | $18.7M | 7.34% |
| 4 | CG ONCOLOGY INC | CGON | 593,262 | $17.0M | 6.66% |
| 5 | VAXCYTE INC | PCVX | 204,285 | $16.7M | 6.55% |
| 6 | CYTOKINETICS INC | CYTK | 348,364 | $16.4M | 6.42% |
| 7 | CARGO THERAPEUTICS INC | 14179K101 | 1,007,677 | $14.5M | 5.69% |
| 8 | CELCUITY INC | CELC | 1,063,783 | $13.9M | 5.45% |
| 9 | SYNDAX PHARMACEUTICALS INC | SNDX | 988,528 | $13.1M | 5.12% |
| 10 | XENON PHARMACEUTICALS INC | XENE | 322,470 | $12.6M | 4.95% |
| 11 | ARGENX SE | ARGX | 19,754 | $12.1M | 4.76% |
| 12 | COGENT BIOSCIENCES INC | COGT | 1,498,425 | $11.7M | 4.58% |
| 13 | MERUS N V | N5749R100 | 234,637 | $9.9M | 3.86% |
| 14 | CONTINEUM THERAPEUTICS INC | CTNM | 573,022 | $8.4M | 3.29% |
| 15 | ABIVAX SA | AAVXF | 653,071 | $4.8M | 1.87% |
| 16 | KALVISTA PHARMACEUTICALS INC | KALV | 556,489 | $4.7M | 1.85% |
| 17 | INOZYME PHARMA INC | 45790W108 | 1,374,582 | $3.8M | 1.49% |
| 18 | IRONWOOD PHARMACEUTICALS INC | IRWD | 814,533 | $3.6M | 1.41% |
| 19 | AMYLYX PHARMACEUTICALS INC | AMLX | 889,073 | $3.4M | 1.32% |
| 20 | CRINETICS PHARMACEUTICALS IN | CRNX | 59,125 | $3.0M | 1.18% |
| 21 | SILENCE THERAPEUTICS PLC | SLNCF | 395,024 | $2.7M | 1.06% |
| 22 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 100,000 | $2.6M | 1.01% |
| 23 | OCULAR THERAPEUTIX INC | OCUL | 191,456 | $1.6M | 0.64% |
| 24 | MBX BIOSCIENCES INC | MBX | 18,000 | $331,740 | 0.13% |